Cost effectiveness of fulvestrant as an additional endocrine step in the treatment sequence for hormone responsive advanced breast cancer

被引：0
|
作者：
Hirsch, M. W.
Gait, C.
Chambers, J.
机构：
[1] AstraZeneca UK Ltd, Macclesfield, Cheshire, England
[2] Mapi Values Ltd, Macclesfield, Cheshire, England
来源：
VALUE IN HEALTH | 2006年 / 9卷 / 06期
关键词：
D O I：
10.1016/S1098-3015(10)63472-9
中图分类号：
F [经济];
学科分类号：
02 ;
摘要：
引用
下载
收藏
页码：A288 / A288
页数：1
相关论文
共 50 条
  • [31] Endocrine treatment of advanced breast cancer
    Dowsett, M
    ACTA ONCOLOGICA, 1996, 35 (05) : 68 - 72
  • [32] Endocrine treatment in advanced breast cancer
    Mouridsen, HT
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 975 - 975
  • [33] Fulvestrant in the paliative treatment of hormone-sensitive breast Cancer
    Kolasinska-Cwikla, Agnieszka
    ONCOLOGY IN CLINICAL PRACTICE, 2014, 10 : F5 - F7
  • [34] Cost-effectiveness of adjuvant endocrine treatment with tamoxifen for male breast cancer
    Huang, Yaping
    Ke, Chengjie
    Cai, Jiaqin
    Wei, Xiaoxia
    Chen, Maohua
    Sun, Hong
    BREAST CANCER, 2024, 31 (05) : 917 - 925
  • [35] Proper sequence of endocrine therapies in advanced breast cancer
    Rose, C
    ACTA ONCOLOGICA, 1996, 35 (05) : 44 - 49
  • [36] EFFECT OF FULVESTRANT TREATMENT ON SERUM VEGF LEVELS IN HORMONE-SENSITIVE ADVANCED BREAST CANCER PATIENTS
    Camerini, A.
    Garrone, O.
    Valsuani, C.
    Tartarelli, G.
    Porta, R. Prosperi
    Siclari, O.
    Rondini, M.
    Puccetti, C.
    Donati, S.
    Amoroso, D.
    ANNALS OF ONCOLOGY, 2009, 20 : 47 - 47
  • [37] COST-EFFECTIVENESS ANALYSIS OF FULVESTRANT IN THE TREATMENT OF METASTATIC BREAST CANCER IN SECOND-LINE CHEMOTHERAPY
    Krysanov, I
    Krysanova, V
    VALUE IN HEALTH, 2014, 17 (07) : A637 - A637
  • [38] Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
    Blancas, I.
    Fontanillas, M.
    Conde, V.
    Lao, J.
    Martinez, E.
    Sotelo, M. J.
    Jaen, A.
    Bayo, J. L.
    Carabantes, F.
    Illarramendi, J. J.
    Gordon, M. M.
    Cruz, J.
    Garcia-Palomo, A.
    Mendiola, C.
    Perez-Ruiz, E.
    Bofill, J. S.
    Baena-Canada, J. M.
    Janez, N. M.
    Esquerdo, G.
    Ruiz-Borrego, M.
    CLINICAL & TRANSLATIONAL ONCOLOGY, 2018, 20 (07): : 862 - 869
  • [39] Efficacy of fulvestrant in the treatment of postmenopausal women with endocrine-resistant advanced breast cancer in routine clinical practice
    I. Blancas
    M. Fontanillas
    V. Conde
    J. Lao
    E. Martínez
    M. J. Sotelo
    A. Jaen
    J. L. Bayo
    F. Carabantes
    J. J. Illarramendi
    M. M. Gordon
    J. Cruz
    A. García-Palomo
    C. Mendiola
    E. Pérez-Ruiz
    J. S. Bofill
    J. M. Baena-Cañada
    N. M. Jáñez
    G. Esquerdo
    M. Ruiz-Borrego
    Clinical and Translational Oncology, 2018, 20 : 862 - 869
  • [40] Cost-effectiveness of palbociclib in hormone receptor-positive advanced breast cancer
    Mamiya, H.
    Tahara, R. K.
    Tolaney, S. M.
    Choudhry, N. K.
    Najafzadeh, M.
    ANNALS OF ONCOLOGY, 2017, 28 (08) : 1825 - 1831
12345